Amarin Technologies SA
About Amarin Technologies SA
Certifications
Categories
-
AR
-
2019On CPHI since
-
2Certificates
-
25 - 49Employees
Company types
Primary activities
Products from Amarin Technologies SA (3)
-
Product Buprenorphine Patch
Amarin has developed a patch intended to be AB rated to Butrans®, but with the comparative advantages of having half of the drug content and also a reduced size (having less residual drug after 7 days of use). As the patch delivers the same amount of drug, this makes it more efficient.
O... -
Product Fentanyl Patch
Fentanyl is a synthetic analgesic related to phenylpiperidines, which interacts predominately with the opioid μ-receptor. Fentanyl primary actions are analgesia and sedation. Minimum effective analgesic serum concentrations of fentanyl in opioid naive patients range from 0.2 to 1.2 ng/mL, and side effects ... -
Product Methylphenidate Patch
Amarin patch is 33% smaller ant it also has one third less of the drug content. As the patch delivers the same amount of drug, this makes it 149% more efficient in comparison to the originator.
Additionally, there has been multiple customers complains on Dyatrana due to backing ...
Amarin Technologies SA Resources (1)
-
Brochure Amarin Presentation
Amarin PPT Presentation
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance